163 related articles for article (PubMed ID: 9453067)
1. Heparin absorption across the intestine: effects of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate in rat in situ intestinal instillations and in Caco-2 monolayers.
Brayden D; Creed E; O'Connell A; Leipold H; Agarwal R; Leone-Bay A
Pharm Res; 1997 Dec; 14(12):1772-9. PubMed ID: 9453067
[TBL] [Abstract][Full Text] [Related]
2. Impact of Sodium
Li Y; Yang D; Zhu C
Molecules; 2018 Nov; 23(11):. PubMed ID: 30453465
[TBL] [Abstract][Full Text] [Related]
3. Pathway of oral absorption of heparin with sodium N-[8-(2-hydroxybenzoyl)amino] caprylate.
Malkov D; Wang HZ; Dinh S; Gomez-Orellana I
Pharm Res; 2002 Aug; 19(8):1180-4. PubMed ID: 12240944
[TBL] [Abstract][Full Text] [Related]
4. Orally administered heparin for preventing deep venous thrombosis.
Gonze MD; Manord JD; Leone-Bay A; Baughman RA; Garrard CL; Sternbergh WC; Money SR
Am J Surg; 1998 Aug; 176(2):176-8. PubMed ID: 9737627
[TBL] [Abstract][Full Text] [Related]
5. [Studies on gastrointestinal absorption enhancement effect and mechanism of sodium N-[8-(2-hydroxybenzyl)amino] caprylate to insulin solution].
Qi R; Ping QN; Zhao W
Yao Xue Xue Bao; 2003 Dec; 38(12):953-6. PubMed ID: 15040094
[TBL] [Abstract][Full Text] [Related]
6. Oral delivery of anticoagulant doses of heparin. A randomized, double-blind, controlled study in humans.
Baughman RA; Kapoor SC; Agarwal RK; Kisicki J; Catella-Lawson F; FitzGerald GA
Circulation; 1998 Oct; 98(16):1610-5. PubMed ID: 9778325
[TBL] [Abstract][Full Text] [Related]
7. Mechanistic understanding of oral drug absorption enhancement of cromolyn sodium by an amino acid derivative.
Alani AW; Robinson JR
Pharm Res; 2008 Jan; 25(1):48-54. PubMed ID: 17846867
[TBL] [Abstract][Full Text] [Related]
8. Salcaprozate sodium (SNAC) enhances permeability of octreotide across isolated rat and human intestinal epithelial mucosae in Ussing chambers.
Fattah S; Ismaiel M; Murphy B; Rulikowska A; Frias JM; Winter DC; Brayden DJ
Eur J Pharm Sci; 2020 Nov; 154():105509. PubMed ID: 32777258
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the effects of the intestinal permeation enhancers, SNAC and sodium caprate (C
Twarog C; McCartney F; Harrison SM; Illel B; Fattal E; Brayden DJ
Eur J Pharm Sci; 2021 Mar; 158():105685. PubMed ID: 33359131
[TBL] [Abstract][Full Text] [Related]
10. Orally administered unfractionated heparin with carrier agent is therapeutic for deep venous thrombosis.
Gonze MD; Salartash K; Sternbergh WC; Baughman RA; Leone-Bay A; Money SR
Circulation; 2000 Jun; 101(22):2658-61. PubMed ID: 10840020
[TBL] [Abstract][Full Text] [Related]
11. A head-to-head Caco-2 assay comparison of the mechanisms of action of the intestinal permeation enhancers: SNAC and sodium caprate (C
Twarog C; Liu K; O'Brien PJ; Dawson KA; Fattal E; Illel B; Brayden DJ
Eur J Pharm Biopharm; 2020 Jul; 152():95-107. PubMed ID: 32387703
[TBL] [Abstract][Full Text] [Related]
12. Investigation of the enhancing mechanism of sodium N-[8-(2-hydroxybenzoyl)amino]caprylate effect on the intestinal permeability of polar molecules utilizing a voltage clamp method.
Hess S; Rotshild V; Hoffman A
Eur J Pharm Sci; 2005 Jun; 25(2-3):307-12. PubMed ID: 15911227
[TBL] [Abstract][Full Text] [Related]
13. Oral absorption enhancement of cromolyn sodium through noncovalent complexation.
Ding X; Rath P; Angelo R; Stringfellow T; Flanders E; Dinh S; Gomez-Orellana I; Robinson JR
Pharm Res; 2004 Dec; 21(12):2196-206. PubMed ID: 15648250
[TBL] [Abstract][Full Text] [Related]
14. Oral delivery of heparin in combination with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate: pharmacological considerations.
Rivera TM; Leone-Bay A; Paton DR; Leipold HR; Baughman RA
Pharm Res; 1997 Dec; 14(12):1830-4. PubMed ID: 9453076
[No Abstract] [Full Text] [Related]
15. Development and In Vitro and In Vivo Evaluation of Microspheres Containing Sodium
Li Y; Zhu C
Molecules; 2020 Apr; 25(8):. PubMed ID: 32340157
[TBL] [Abstract][Full Text] [Related]
16. Intestinal absorptivity-increasing effects of sodium N-[8-(2-hydroxybenzoyl)amino]-caprylate on food-derived bioactive peptide.
Xu Y; Amakye WK; Xiao G; Liu X; Ren J; Wang M
Food Chem; 2023 Feb; 401():134059. PubMed ID: 36095999
[TBL] [Abstract][Full Text] [Related]
17. Colonic absorption of salmon calcitonin using tetradecyl maltoside (TDM) as a permeation enhancer.
Petersen SB; Nielsen LG; Rahbek UL; Guldbrandt M; Brayden DJ
Eur J Pharm Sci; 2013 Mar; 48(4-5):726-34. PubMed ID: 23354154
[TBL] [Abstract][Full Text] [Related]
18. Elucidating a Potential Mechanism of Permeability Enhancer Sodium N-[8-(2-hydroxybenzoyl) amino] Caprylate in Rats: Evidence of Lymphatic Absorption of Cyanocobalamin using the Mesenteric Lymph Duct Cannulated Rat.
Chiang PC; Liu J; Nagapudi K; Wu R; Dolton M; Chen J; Plise E; Liu L; Durk MR
J Pharm Sci; 2022 Dec; 111(12):3417-3423. PubMed ID: 36228756
[TBL] [Abstract][Full Text] [Related]
19. Enhancement of colonic drug absorption by the transcellular permeation route.
Tomita M; Hayashi M; Horie T; Ishizawa T; Awazu S
Pharm Res; 1988 Dec; 5(12):786-9. PubMed ID: 3247289
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of oral cyanocobalamin formulated with sodium N-[8-(2-hydroxybenzoyl)amino]caprylate (SNAC): an open-label, randomized, single-dose, parallel-group study in healthy male subjects.
Castelli MC; Wong DF; Friedman K; Riley MG
Clin Ther; 2011 Jul; 33(7):934-45. PubMed ID: 21722960
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]